Proteasomal degradation of tau protein
Open accessAbstract
Filamentous inclusions composed of the microtubule-associated protein tau are a defining characteristic of a large number of neurodegenerative diseases. Here we show that tau degradation in stably transfected and non-transfected SH-SY5Y cells is blocked by the irreversible proteasome inhibitor lactacystin. Further, we find that in vitro, natively unfolded tau can be directly processed by the 20S proteasome without a requirement for ubiquitylation, and that a highly reproducible pattern of degradation intermediates is readily detectable during this process. Analysis of these intermediates shows that 20S proteasomal processing of tau is bi-directional, proceeding from both N- and C-termini, and that populations of relatively stable intermediates arise probably because of less efficient digestion of the C-terminal repeat region. Our results are consistent with an in vivo role for the proteasome in tau degradation and support the existence of ubiquitin-independent pathways for the proteasomal degradation of unfolded proteins.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some basal interaction between tau and CRL4CRBN E3 ligase may occur endogenously in human neurons.
“suggesting that some basal interaction between tau and the CRL4CRBN E3 ligase may also occur endogenously in human neurons, as has been reported in tissue from mouse brain”
From Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models (2019) · cites this paper as David et al., 2002
The citation lists haven’t been fetched yet
References 57 · Cited by 327
- Authors
- David, D. C., Layfield, R., Serpell, L., Narain, Y., Goedert, M., & Spillantini, M. G.
- Affiliations
- University of Cambridge (GB)
- MRC Laboratory of Molecular Biology (GB)
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2002-09-18
- Volume
- 83
- Issue
- 1
- Pages
- 176-185
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1544371346
- Cited by
- 327
- References
- 57
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 15 · 2020: 11 · 2019: 17 · 2018: 16 · 2017: 17 · 2016: 10 · 2015: 14 · 2014: 12 · 2013: 14 · 2012: 19
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- tau protein, proteasomal degradation, 20S proteasome, lactacystin, ubiquitin-independent degradation, intrinsically disordered proteins, degradation intermediates, neurodegenerative diseases, SH-SY5Y cells, microtubule-associated proteins
- MeSH terms
- Acetylcysteine, Cysteine Endopeptidases, Humans, Multienzyme Complexes, Neuroblastoma, Transfection, Tumor Cells, Cultured, Blotting, Western, Cysteine Proteinase Inhibitors, tau Proteins, Protein Folding, Protein Isoforms, Ubiquitin, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review